Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $30.8B
1-Year Est. Return 20.65%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+20.65%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$29.6B
AUM Growth
+$2.54B
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
1,389
New
Increased
Reduced
Closed

Top Buys

1 +$163M
2 +$139M
3 +$137M
4
CCI icon
Crown Castle
CCI
+$118M
5
NFLX icon
Netflix
NFLX
+$115M

Top Sells

1 +$130M
2 +$123M
3 +$108M
4
MAA icon
Mid-America Apartment Communities
MAA
+$77.2M
5
WELL icon
Welltower
WELL
+$73M

Sector Composition

1 Technology 30%
2 Real Estate 28.67%
3 Communication Services 10.86%
4 Consumer Discretionary 6.91%
5 Financials 5.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XLV icon
1201
State Street Health Care Select Sector SPDR ETF
XLV
$41.9B
$5K ﹤0.01%
33
ZLAB icon
1202
Zai Lab
ZLAB
$1.99B
$5K ﹤0.01%
150
-43
ZYME icon
1203
Zymeworks
ZYME
$1.9B
$5K ﹤0.01%
286
AMLX icon
1204
Amylyx Pharmaceuticals
AMLX
$1.65B
$4K ﹤0.01%
266
AMPH icon
1205
Amphastar Pharmaceuticals
AMPH
$917M
$4K ﹤0.01%
135
-50
ARDX icon
1206
Ardelyx
ARDX
$1.63B
$4K ﹤0.01%
754
COLL icon
1207
Collegium Pharmaceutical
COLL
$1.26B
$4K ﹤0.01%
127
CVAC
1208
DELISTED
CureVac
CVAC
$4K ﹤0.01%
697
DVAX
1209
DELISTED
Dynavax Technologies
DVAX
$4K ﹤0.01%
409
GRFS icon
1210
Grifois
GRFS
$5.89B
$4K ﹤0.01%
398
INVA icon
1211
Innoviva
INVA
$1.7B
$4K ﹤0.01%
238
NVAX icon
1212
Novavax
NVAX
$1.61B
$4K ﹤0.01%
492
-160
PCRX icon
1213
Pacira BioSciences
PCRX
$940M
$4K ﹤0.01%
169
SPRY icon
1214
ARS Pharmaceuticals
SPRY
$894M
$4K ﹤0.01%
367
STOK icon
1215
Stoke Therapeutics
STOK
$1.97B
$4K ﹤0.01%
175
TXG icon
1216
10x Genomics
TXG
$2.86B
$4K ﹤0.01%
370
USIG icon
1217
iShares Broad USD Investment Grade Corporate Bond ETF
USIG
$16.8B
$4K ﹤0.01%
80
-33
WVE icon
1218
Wave Life Sciences
WVE
$2.55B
$4K ﹤0.01%
503
XLF icon
1219
State Street Financial Select Sector SPDR ETF
XLF
$50.4B
$4K ﹤0.01%
72
LENZ
1220
LENZ Therapeutics
LENZ
$411M
$4K ﹤0.01%
91
RAPP
1221
Rapport Therapeutics
RAPP
$1.33B
$4K ﹤0.01%
121
ORIC icon
1222
Oric Pharmaceuticals
ORIC
$1.51B
$3K ﹤0.01%
249
PHAT icon
1223
Phathom Pharmaceuticals
PHAT
$863M
$3K ﹤0.01%
260
PRAX icon
1224
Praxis Precision Medicines
PRAX
$9.05B
$3K ﹤0.01%
62
ANAB icon
1225
AnaptysBio
ANAB
$1.68B
$3K ﹤0.01%
105